LANGLARA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
87682-090 -
Package NDC
87682-090-05 -
Application number
BLA761412 -
SPL ID
5dececb8-5164-dca7-e063-6394a90ae2b8 -
SPL set ID
5328761e-59d3-ca7a-e063-6394a90ae810 -
UNII
2ZM8CX04RZ -
RxCUI
2746568 -
RxCUI
2746571
What the source publishes
- Labeler
- Lanexa Biologics, LLC
- Active ingredients
- insulin glargine-aldy
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "LANGLARA",
"splId": "5dececb8-5164-dca7-e063-6394a90ae2b8",
"labels": [
{
"setId": "5328761e-59d3-ca7a-e063-6394a90ae810",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5328761e-59d3-ca7a-e063-6394a90ae810",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5328761e-59d3-ca7a-e063-6394a90ae810"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Lanexa Biologics, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "5 SYRINGE in 1 CARTON (87682-090-05) / 3 mL in 1 SYRINGE (87682-090-01)",
"package_ndc": "87682-090-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20260701"
}
],
"productId": "87682-090_5dececb8-5164-dca7-e063-6394a90ae2b8",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "87682-090",
"deaSchedule": null,
"genericName": "insulin glargine-aldy",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INSULIN GLARGINE",
"strength": "100 [iU]/mL"
}
],
"applicationNumber": "BLA761412",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260701",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0011417",
"N0000175453"
],
"unii": [
"2ZM8CX04RZ"
],
"rxcui": [
"2746568",
"2746571"
],
"spl_set_id": [
"5328761e-59d3-ca7a-e063-6394a90ae810"
],
"pharm_class_cs": [
"Insulin [CS]"
],
"pharm_class_epc": [
"Insulin Analog [EPC]"
],
"manufacturer_name": [
"Lanexa Biologics, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:87682-090_5dececb8-5164-dca7-e063-6394a90ae2b8"